Myeloid cell responses after spinal cord injury
David, Samuel (Centre for Research in Neuroscience. The Research Institute of the McGill University Health Center)
Kroner, A. (Clement J. Zablocki Veterans Affairs Medical Center. Department of Neurosurgery. Medical College of Wisconsin)
Greenhalgh, A. D. (Laboratory of Nutrition and Integrated Neurobiology. INRA. University of Bordeaux)
Zarruk, J. G. (Centre for Research in Neuroscience. The Research Institute of the McGill University Health Center)
López Vales, Rubén (Universitat Autònoma de Barcelona. Institut de Neurociències)
Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia

Data:	2018
Ajuts:	Ministerio de Economía y Competitividad SAF2016-79774-R
Nota:	The work done in the authors labs were supported by grants from the Canadian Institutes of Health Research (MOP-14828 and MOP-142231), and the MS Society of Canada (#2112) (SD); Wings for Life Spinal Cord Research Foundation (WFL-US-13/16), and Advancing a Healthier Wisconsin Endowment (5520363) (AK); and the Spanish Ministry of Economy and Competiiveness (SAF2016-79774-R), International Foundation for Research in Paraplegia (P148), Wings for Life Spinal Cord Research Foundation (WFL-ES-14/17) and by funds from the Fondo de Investigación Sanitaria of Spain (TERCEL and CIBERNED) (RLV). We also wish to thank our many collaborators. The past decade has revealed much about the complexity of the local inflammatory response after spinal cord injury (SCI). A major challenge is to distinguish between microglia and monocyte-derived macrophages (MDMs) to determine their phenotype and function. Transcriptome studies have revealed microglia-selective genes but are still limited in scope because many markers are downregulated after injury. Additionally, new genetic reporter mice are available to study microglia and MDMs. There is more evidence now for the plasticity and heterogeneity of microglia and MDMs. We also discuss the role of neutrophils that are the first peripheral cells to enter the injured CNS.
Nota:	Altres ajuts: International Foundation for Research in Paraplegia: WFL-ES-14/17, P148; Wings for Life: WFL-US-13/16; Advancing a Healthier Wisconsin Endowment: 5520363; MS Society of Canada: 2112; Canadian Institutes of Health Research:MOP-14828, MOP-142231
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió acceptada per publicar
Publicat a:	Journal of Neuroimmunology, Vol. 321 (Aug. 2018) , p. 97-108, ISSN 1872-8421

DOI: 10.1016/j.jneuroim.2018.06.003
PMID: 29957394

Postprint 49 p, 575.7 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Neurociències (INc)
Articles > Articles de recerca
Articles > Articles publicats